Acme Progen Biotech (India) Private Limited

Acme Progen Biotech (India) Private Limited - research & development in Salem, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U33111TZ2007PTC013847 Incorporated 10 July 2007 ROC Coimbatore HQ Salem, Tamil Nadu, India
Active Private Limited Company research and development MSME · Micro
Revenue · FY 2024
₹90.39 Lakh
▲ 9% YoY
Net profit · FY 2024
₹72,839
Net margin 0.8%
EBITDA · FY 2024
₹9.6 Lakh
EBITDA margin 10.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Satisfied charges
₹19 Lakh
No open charges
Company age
19 yrs
Est. 2007
Directors on board
3
As per MCA filings

About Acme Progen Biotech (India) Private Limited

Data last updated:

Acme Progen Biotech (India) Private Limited is a private limited company based in Salem, Tamil Nadu, India. It operates in the research and development sector. It was incorporated on 10 July 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U33111TZ2007PTC013847. Its GSTIN is 33AAGCA4241G1Z4 (Tamil Nadu).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Venkatesan Ganesan and Appuchigounder Rathanam.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Rams Square 260 G Balaji Nagar Advaitha Ashram Road, Salem, Tamil Nadu, India – 636004.

As per the financials filed for FY 2024, the company reported a revenue of ₹90.39 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹72,839 (net margin 0.8%) and EBITDA of ₹9.6 Lakh (EBITDA margin 10.6%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 2% over five years.

As per MCA filings, the company has satisfied charges of ₹19 Lakh on record.

Acme Progen Biotech (India) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-20-0010621). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website acmeprogen.com.

Company details

CIN U33111TZ2007PTC013847
Registration Number 013847
Incorporation Date 10 July 2007
ROC Coimbatore
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-20-0010621

Recognitions & Rankings of Acme Progen Biotech (India)

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-TN-20-0010621

Contact details

Acme Progen Biotech (India) Private Limited's registered office is in Salem, Tamil Nadu. Its website is acmeprogen.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Rams Square 260 G Balaji Nagar Advaitha Ashram Road, Salem, Tamil Nadu, India – 636004
  • Industry
    Research & Development, Research & Development

To see the full contact details of Acme Progen Biotech (India) Private Limited, buy the company report.

Comprehensive company report
Acme Progen Biotech (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Acme Progen Biotech (India) is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Acme Progen Biotech (India) Private Limited, buy the company report.

Financials of Acme Progen Biotech (India) Private Limited

FY 2025 filings available

Acme Progen Biotech (India) Private Limited reported revenue of ₹90.39 Lakh (up 9% YoY) for FY 2024.

Revenue · FY 2024
₹90.39 Lakh ▲ 9%
Net profit · FY 2024
₹72,839 margin 0.8%
EBITDA · FY 2024
₹9.6 Lakh margin 10.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▼ 14%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 1%
3 years · compounded
▼ 5%
5 years · compounded
▲ 22%

Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 9% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹9.6 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹72,839
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin10.6%
Net Profit Margin0.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Acme Progen Biotech (India) Private Limited, buy the company report.

Board of directors of Acme Progen Biotech (India) Private Limited

Acme Progen Biotech (India) has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Venkatesan GanesanDirector30 Nov 20214 Years 11 MonthsCurrent
Appuchigounder RathanamDirector04 Apr 20188 Years 7 MonthsCurrent
Mani ChitraDirector10 Jul 200719 Years 4 MonthsCurrent

Peer comparison

Acme Progen Biotech (India) Private Limited is compared with the 8 companies closest to it by revenue in the same principal business activity (scientific research and development), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Aindra Systems Private Limited₹91.19 Lakh (FY 2024)195.0%Bengaluru, Karnataka, India
Serigen Mediproducts Private Limited₹91.08 Lakh (FY 2025)338.0%Pune, Maharashtra, India
Mithra Increst Private Limited₹90.93 Lakh (FY 2024)-89.0%Bangalore, Karnataka, India
JK Material Test House Infracon and Consultancy Private Limited₹90.46 Lakh (FY 2025)327.0%Rajauri, Jammu and Kashmir, India
Acme Progen Biotech (India) Private Limitedthis company₹90.39 Lakh (FY 2024)₹72,8390.8%9.0%Salem, Tamil Nadu, India
Paryani Diagnostics Centre Private Limited₹90.23 Lakh (FY 2025)7.0%Indore, Madhya Pradesh, India
Evoscien Private Limited₹89.99 Lakh (FY 2025)-7.0%Bengaluru, Karnataka, India
Indglobl Nextgen Medicare Limited₹88.5 Lakh (FY 2019)53.0%Chengalpattu, Tamil Nadu, India
QCC Lab Solutions Private Limited₹88.14 Lakh (FY 2025)-15.0%Mumbai, Maharashtra, India

To see the full peer comparison of Acme Progen Biotech (India) Private Limited, buy the company report.

Auditor

Acme Progen Biotech (India) Private Limited is audited by M SEKAR for the financial year 2017.

Auditor firmFinancial yearFirm registration number
M SEKARFY 2017215473

Shareholding

The shareholding of Acme Progen Biotech (India) Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Acme Progen Biotech (India) Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹19 Lakh
Breakdown by lending institutions
Indian Bank₹0.10 Cr
The Lakshmi Vilas Bank Ltd₹0.09 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Jun 2018100212631Indian Bank₹10 LakhSatisfied
05 Dec 200710109353The Lakshmi Vilas Bank Ltd₹9 LakhSatisfied

To see the full charge records of Acme Progen Biotech (India) Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Acme Progen Biotech (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Acme Progen Biotech (India) has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AAGCA4241G1Z4Tamil NaduActive01 Jul 2017

To see the full GST registrations and return filing status of Acme Progen Biotech (India) Private Limited, buy the company report.

Recent activity

Acme Progen Biotech (India) Private Limited has 6 board changes on record since 2007: 3 appointments and 3 cessations. The latest: Venkatesan Ganesan was appointed as Director on 30 Nov 2021.

AGM
Acme Progen Biotech (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Acme Progen Biotech (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Coimbatore.
Charges
A charge registered on 27 Jun 2018 via Charge ID 100212631 with Indian Bank was fully satisfied on 05 Oct 2024.
Appointed
Venkatesan Ganesan was appointed as Director.
Charges
A charge with Indian Bank of Rs. 10.00 Lakh registered on 27 Jun 2018 with Charge ID 100212631 was modified on 06 Jul 2019.
Ceased
Appuchigounder Rathanam ceased to be Additional Director.
Charges
A charge with Indian Bank amounted to Rs. 10.00 Lakh with Charge ID 100212631 was registered on 27 Jun 2018.
Appointed
Appuchigounder Rathanam was appointed as Director.
Ceased
Venkatesan Ganesan ceased to be Managing Director.
Ceased
Mani Suganthi ceased to be Additional Director.
Charges
A charge registered on 05 Dec 2007 via Charge ID 10109353 with The Lakshmi Vilas Bank Ltd was fully satisfied on 06 May 2010.
Charges
A charge with The Lakshmi Vilas Bank Ltd amounted to Rs. 9.00 Lakh with Charge ID 10109353 was registered on 05 Dec 2007.

2 earlier events are in the company report.

Frequently asked questions

Acme Progen Biotech (India) is an active private limited company based in Salem, Tamil Nadu, India. The company works in the research and development industry. It was incorporated on 10 July 2007 (19+ years old) and is registered under CIN U33111TZ2007PTC013847.

Acme Progen Biotech (India) has 3 current directors:

The latest financial statements of Acme Progen Biotech (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Acme Progen Biotech (India) is 33AAGCA4241G1Z4, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Acme Progen Biotech (India) is U33111TZ2007PTC013847. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Acme Progen Biotech (India) was incorporated on 10 July 2007, making it 19+ years old. It is registered with the Registrar of Companies, Coimbatore.

The peers of Acme Progen Biotech (India) by revenue are Aindra Systems Private Limited, Serigen Mediproducts Private Limited, Mithra Increst Private Limited, JK Material Test House Infracon and Consultancy Private Limited, Paryani Diagnostics Centre Private Limited and 3 more, all in the same principal business activity (scientific research and development).

Venkatesan Ganesan was appointed as Director on 30 Nov 2021. Appuchigounder Rathanam ceased to be Additional Director on 29 Sep 2018. Appuchigounder Rathanam was appointed as Director on 04 Apr 2018. Acme Progen Biotech (India) has 6 board changes on record in total.

Yes, Acme Progen Biotech (India) is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-20-0010621).

Acme Progen Biotech (India) can be reached through the website acmeprogen.com. Its registered office is in Salem, Tamil Nadu, India.

The registered office of Acme Progen Biotech (India) is at Rams Square 260 G Balaji Nagar Advaitha Ashram Road, Salem, Tamil Nadu, India – 636004.